Methyl 2-(2-chloroethylaminocarbonyl)diazenecarboxylate SB-166 inhibits the growth of different tumour cell lines, including drug-resistant sublines

Toxicology in Vitro

Volumn 17, Issue 2, 2003, Pages 159-164

  Cimbora T ^a   Bombek, S ^b   Polanc, S ^b   Osmak, M ^c  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c NONE

Author keywords

Anticancer drugs; Diazenecarboxamides; Diazenedicarboxamides; Drug resistance; Glutathione

Indexed keywords

ANTINEOPLASTIC AGENT; JK 1090; METHYL 2 (2 CHLOROETHYLAMINOCARBONYL)DIAZENECARBOXYLATE; METHYL 2 [(CYCLOHEXYLAMINO)CARBONYL]DIAZENECARBOXYLATE; METHYL 5 BENZOYL 3 (2 CHLOROETHYL) 2 OXO 4 PHENYL 2,3 DIHYDRO 1H IMIDAZOL 1 YLCARBAMATE; N (4 IODOPHENYL) 2 (2 PYRIDINYL)DIAZENECARBOXAMIDE; N 1 (2 CHLOROETHYL) N 2 (2 PYRIDINYLMETHYL) 1,2 DIAZENEDICARBOXAMIDE; N 1 (2 CHLOROETHYL) N 2 (4 ISOPROPYLPHENYL) 1,2 DIAZENEDICARBOXAMIDE; N 1 (4 SEC BUTYLPHENYL) N 2 (2 CHLOROETHYL) 1,2 DIAZENEDICARBOXAMIDE; N 1 (4 TERT BUTYLPHENYL) N 2 (2 CHLOROETHYL) 1,2 DIAZENEDICARBOXAMIDE; N PHENYL 2 (2 QUINOLINYL)DIAZENECARBOXAMIDE; SB 166; SB 178; SB 282; SB 410; SB 472; SB 474; SB 503; UNCLASSIFIED DRUG; UP 140;

ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RESISTANCE; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SYNTHESIS; GLIOBLASTOMA; HUMAN; HUMAN CELL; LARYNX CARCINOMA; UTERINE CERVIX CARCINOMA;

EID: 0037377048     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2333(03)00002-X     Document Type: Article

References (31)

1. Beaver J.P., Waring P. A decrease in intracellular glutathione concentration precedes the onset of apoptosis in murine thymocytes. European Journal of Cell Biology. 68:1995;47-54.
2. Beck W.T., Morgan S.E., Mo Y.Y., Bhat U.G. Tumor cell resistance to DNA topoisomerase II inhibitors. new developments Drug Resistance Updates. 2:1999;382-389.
3. Beketić-Orešković L., Osmak M. Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): Cross-resistance pattern. Neoplasma. 41:1994;171-176.
4. Bombek S., Lenaršič R., Kočevar M., Polanc S. A new and straightforward approach to highly functionalized 2-imidazolin-2-ones. Synlett. 2001;1237-1240.
5. Burdon R.H., Gill V., Alliangana D. Hydrogen peroxide in relation to proliferation and apoptosis in BHK-21 hamster fibroblasts. Free Radical Research. 24:1996;81-83.
6. Cnubben N.H.P., Rietjens I.M.C.M., Wortelboer H., van Zanden J., van Bladeren P.J. The interplay of glutathione-related processes in antioxidant defense. Environmental Toxicology and Pharmacology. 10:2001;141-152.
7. Damiano J.S., Dalton W.S. Integrin-mediated drug resistance in multiple myeloma. Leukemia and Lymphoma. 38:2000;71-81.
8. Dean M., Rzhetsky A., Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Research. 11:2001;1156-1166.
9. Ghibelli L., Coppola S., Rotilio G., Lafavia E., Maresca V., Ciriolo M.R. Non-oxidative loss of glutathione in apoptosis via GSH extrusion. Biochemical and Biophysical Research Communications. 216:1995;313-320.
10. Kearns P.R., Hall A.G. Glutathione and the response of malignant cells to chemotherapy. Drug Discovery Today. 3:1998;113-121.
11. Knapen M.F.C.M., Zusterzeel P.L.M., Peters W.H.M., Stegeers E.A.P. Glutathione and glutathione related enzymes in reproduction - a review. European Journal of Obstetrics, Gynecology and Reproductive Biology. 82:1999;171-184.
12. Košmrlj J., Kočevar M., Polanc S. Controlled oxidation of thiols to disulfides by diazenecarboxamides. Journal of the Chemical Society, Perkin Transactions. 1:1998;3917-3919.
13. Lide, D.R., Frederikse, H.P. (Eds.), 1995. CRC Handbook of Chemistry and Physics, seventy-sixth ed., CRC Press, Boca Raton, FL, pp. 8-49.
14. Locigno R., Castronovo V. Reduced glutathione system: Role in cancer development, prevention and treatment (review). International Journal of Oncology. 19:2001;221-236.
15. Meister A. Glutathione, ascorbate, and cellular protection. Cancer Research. 54:1994;1969s-1975s.
16. Mickisch G., Fajta S., Keilhauer G., Schlike E., Tschada P., Alken P. Chemosensitivity testing of primary human renal cell carcinoma by tetrazolium based microculture assay (MTT). Urological Research. 18:1990;131-136.
17. Moskatelo D., Benjak A., Vibor L., Polanc S., Košmrlj J., Osmak M. Cytotoxic effect of diazenes on tumor cells in vitro. Chemotherapy. 48:2002;36-41.
18. Mounetou E., Legault J., Lacroix J., Gaudreault R.C. Antimitotic antitumor agents: synthesis, structure-activity relationships, and biological characterization of N-aryl-N′-(2-chloroethyl)ureas as new selective alkylating agents. Journal of Medicinal Chemistry. 44:2001;694-702.
19. O'Gorman D.M., Cotter T.G. Molecular signals in anti-apoptotic survival pathways. Leukemia. 15:2001;21-34.
20. Osmak M. Molecular alterations induced in drug-resistant cells. Radiology and Oncology. 32:1998;19-33.
21. Osmak M., Beketić-Orešković L., Matulić M., Sorić J. Resistance of human larynx carcinoma cells to cisplatin, gamma irradiation and methotrexate do not involve overexpression of c-myc or c-Ki-ras oncogenes. Mutation Research. 303:1993;113-120.
22. Osmak M., Bordukalo T., Jernej B., Košmrlj J., Polanc S. Diazene JK-279. potential anticancer drug Anti-Cancer Drugs. 10:1999;853-859.
23. Osmak M., Bordukalo T., Košmrlj J., Kvajo M., Marijanović Z., Eljuga D., Polanc S. Diazenes: modificators of tumor cell resistance to cisplatin. Neoplasma. 46:1999;201-206.
24. Osmak M., Eljuga D. The response of two vincristine resistant human larynx carcinoma cell clones to chemotherapeutic drugs. Radiology and Oncology. 26:1992;140-144.
25. Osmak M., Eljuga D. The characterization of two human cervical carcinoma HeLa sublines resistant to cisplatin. Research in Experimental Medicine. 193:1993;389-396.
26. Osmak M., Vrhovec I., Škrk J. Cisplatin resistant glioblastoma cells may have increased concentration of urokinase plasminogen activator and plasminogen activator inhibitor type 1. Journal of Neuro-Oncology. 42:1999;95-102.
27. Pieters L., Košmrlj J., Lenaršič R., Kočevar M., Polanc S. Synthesis and cytotoxicity against human cancer cells of novel diazenecarboxamides. Arkivoc. 2(Part 3):2001;U63-U70.
28. Sandstrom P.A., Mannie M.D., Buttke T.M. Inhibition of activation-induced death in T cell hybridomas by thiol antioxidans. oxidative stress as a modulator of apoptosis Journal of Leukocyte Biology. 55:1994;221-226.
29. Schmitt C.A., Lowe S.W. Apoptosis and therapy. Journal of Pathology. 187:1999;127-137.
30. Slater A.F.G., Stefan C., Nobel I., Van den Dobbelsteen D.J., Orrenius S. Signaling mechanisms and oxidative stress in apoptosis. Toxicology Letters. 82:1995;149-153.
31. White A.C., Thannickal V.J., Fanburg B.L. Gultathione deficiency in human disease. Journal of Nutritional Biochemistry. 5:1994;218-226.